30LB Maraviroc administration is associated to reversion of latent HIV-1 through NFkB in ART suppressed patients

• N. Madrid-Elena,
• L. García-Bermejo,
• Adíaz-De Santiago,
• S. Serrano-Villar,
• F. Dronda,
• B. Sastre-Turrón,
• C. Gutierrez,
• B. Hernández-Novoa,
• S. Moreno Guillén

Affiliations

N. Madrid-Elena

HOSPITAL RAMÓN Y CAJAL, Infectious Diseases, Madrid, Spain

L. García-Bermejo

HOSPITAL RAMÓN Y CAJAL, Infectious Diseases, Madrid, Spain

Adíaz-De Santiago

HOSPITAL RAMÓN Y CAJAL, Infectious Diseases, Madrid, Spain

S. Serrano-Villar

HOSPITAL RAMÓN Y CAJAL, Infectious Diseases, Madrid, Spain

F. Dronda

HOSPITAL RAMÓN Y CAJAL, Infectious Diseases, Madrid, Spain

B. Sastre-Turrón

IIS-Fundación Jiménez Díaz, Immunology Department, Madrid, Spain

C. Gutierrez

HOSPITAL RAMÓN Y CAJAL, Infectious Diseases, Madrid, Spain

B. Hernández-Novoa

HOSPITAL RAMÓN Y CAJAL, Infectious Diseases, Madrid, Spain

S. Moreno Guillén

HOSPITAL RAMÓN Y CAJAL, Infectious Diseases, Madrid, Spain